DoW Toxic Exposures Clinical Trial Award
This grant funds clinical trials to advance prevention, treatment, or management of health issues caused by military-related toxic exposures, encouraging collaborative projects between clinicians and researchers.
Funder: Dept. of the Army -- USAMRAA
Due Dates: August 19, 2026: Pre-Application (Preproposal) | November 19, 2026: Full Application | November 24, 2026: End of Application Verification
Funding Amounts: Up to $4.5M total costs per award over up to 4 years; approximately 1 award expected.
Summary: Supports clinical trials advancing prevention, treatment, or management of health outcomes associated with military-related toxic exposures.
Key Information: Requires pre-application via eBRAP; full applications by invitation only.
Description
This funding opportunity supports the advancement, execution, and analysis of clinical trials aimed at preventing, treating, or managing symptoms, diseases, or conditions associated with or resulting from military-related toxic exposures. Projects may range from small proof-of-concept trials to large-scale efficacy trials. The program encourages interdisciplinary collaborations, especially between clinicians and research scientists, through a Partnering Principal Investigator Option (PPIO). The intent is to accelerate translation of promising interventions or knowledge products into clinical application, ultimately improving health outcomes for Service Members, Veterans, their families, and the public.
